- Country: United States
Entities › name
Spyre Therapeutics
9 headlines · 3 outlets · 2026-10-03 → 2026-10-06 · Wikipedia ↗ · 🔒 Follow
Latest coverage
- Press releases
- Country: United States
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater…
- Country: Cyprus
Why is Spyre Therapeutics stock sliding today?
- Country: United States
Spyre Therapeutics announces proposed public offering of common stock
- Country: Cyprus
Spyre Therapeutics launches public stock offering
- Press releases
- Country: United States
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater…
- Country: Cyprus
Spyre Therapeutics’ chief legal officer sells $2.63m in shares
- Country: Cyprus
Spyre Therapeutics CFO Scott Burrows sells $2.26m in stock
- Country: Cyprus